Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

A criterion based sling weaning progression (sweap) and outcomes following shoulder arthroscopic surgery in an active duty military population.

Hire JM, Pniewski JE, Dickston ML, Jacobs JM, Mueller TL, Abell BE, Bojescul JA.

Int J Sports Phys Ther. 2014 Apr;9(2):179-86.

PMID:
24790779
[PubMed]
Free PMC Article
2.

Black horseman lane: a reflection.

Pniewski J.

Narrat Inq Bioeth. 2013 Fall;3(2):117-20. doi: 10.1353/nib.2013.0029. No abstract available.

PMID:
24407081
[PubMed - in process]
3.

The many faces of moral distress among clinicians.

Rushton CH, Boss R, Hallett K, Hensel J, Humphrey GB, Les J, Mack C, McCammon S, Murray JS, Nathanson E, Pniewski J, Shuham AM, Volpe RL.

Narrat Inq Bioeth. 2013 Fall;3(2):89-93. doi: 10.1353/nib.2013.0039.

PMID:
24407071
[PubMed - in process]
4.

Status update and interim results from the asymptomatic carotid surgery trial-2 (ACST-2).

ACST-2 Collaborative Group, Halliday A, Bulbulia R, Gray W, Naughten A, den Hartog A, Delmestri A, Wallis C, le Conte S, Macdonald S.

Eur J Vasc Endovasc Surg. 2013 Nov;46(5):510-8. doi: 10.1016/j.ejvs.2013.07.020. Epub 2013 Sep 17.

PMID:
24051108
[PubMed - indexed for MEDLINE]
5.

Polymorphisms of paraoxonase 1 and 2 genes and the risk of multiple sclerosis in the Polish population.

Zakrzewska-Pniewska B, Nojszewska M, Róg T, Pniewski J, Dorobek M, Styczyńska M, Szczudlik A.

Neurol Neurochir Pol. 2013 Jan-Feb;47(1):49-52.

PMID:
23487294
[PubMed - indexed for MEDLINE]
6.

Anterior cruciate ligament augmentation for rotational instability following primary reconstruction with an accelerated physical therapy protocol.

Carey T, Oliver D, Pniewski J, Mueller T, Bojescul J.

J Surg Orthop Adv. 2013 Spring;22(1):59-65.

PMID:
23449057
[PubMed - indexed for MEDLINE]
7.

Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis.

Radue EW, O'Connor P, Polman CH, Hohlfeld R, Calabresi P, Selmaj K, Mueller-Lenke N, Agoropoulou C, Holdbrook F, de Vera A, Zhang-Auberson L, Francis G, Burtin P, Kappos L; FTY720 Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) Study Group.

Arch Neurol. 2012 Oct;69(10):1259-69.

PMID:
22751847
[PubMed - indexed for MEDLINE]
8.

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.

Devonshire V, Havrdova E, Radue EW, O'Connor P, Zhang-Auberson L, Agoropoulou C, Häring DA, Francis G, Kappos L; FREEDOMS study group.

Lancet Neurol. 2012 May;11(5):420-8. doi: 10.1016/S1474-4422(12)70056-X. Epub 2012 Apr 10. Erratum in: Lancet Neurol. 2012 Aug;11(8):658.

PMID:
22494956
[PubMed - indexed for MEDLINE]
9.

Incidence and case fatality rates of first-ever stroke - comparison of data from two prospective population-based studies conducted in Warsaw.

Sienkiewicz-Jarosz H, Głuszkiewicz M, Pniewski J, Niewada M, Członkowska A, Wolfe C, Ryglewicz D.

Neurol Neurochir Pol. 2011 May-Jun;45(3):207-12.

PMID:
21866477
[PubMed - indexed for MEDLINE]
10.

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.

Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox KM, Hennerici MG, Mattle HP, Rothwell PM, de Cordoüe A, Fratacci MD; PERFORM Study Investigators.

Lancet. 2011 Jun 11;377(9782):2013-22. doi: 10.1016/S0140-6736(11)60600-4. Epub 2011 May 25. Erratum in: Lancet. 2011 Jul 30;378(9789):402.

PMID:
21616527
[PubMed - indexed for MEDLINE]
11.

Developing a tool to assess quality of stroke care across European populations: the EROS Quality Assessment Tool.

Wellwood I, Wu O, Langhorne P, McKevitt C, Di Carlo A, Rudd AG, Wolfe CD; European Registers of Stroke (EROS) Collaborative Group.

Stroke. 2011 May;42(5):1207-11. doi: 10.1161/STROKEAHA.110.598938. Epub 2011 Apr 7.

PMID:
21474805
[PubMed - indexed for MEDLINE]
Free Article
12.

Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.

Comi G, Cohen JA, Arnold DL, Wynn D, Filippi M; FORTE Study Group.

Ann Neurol. 2011 Jan;69(1):75-82. doi: 10.1002/ana.22316.

PMID:
21280077
[PubMed - indexed for MEDLINE]
13.

Three-month stroke outcome: the European Registers of Stroke (EROS) investigators.

Heuschmann PU, Wiedmann S, Wellwood I, Rudd A, Di Carlo A, Bejot Y, Ryglewicz D, Rastenyte D, Wolfe CD; European Registers of Stroke.

Neurology. 2011 Jan 11;76(2):159-65. doi: 10.1212/WNL.0b013e318206ca1e. Epub 2010 Dec 9.

PMID:
21148118
[PubMed - indexed for MEDLINE]
14.

Stroke unit care in clinical practice: an observational study in the Florence center of the European Registers of Stroke (EROS) Project.

Di Carlo A, Lamassa M, Wellwood I, Bovis F, Baldereschi M, Nencini P, Poggesi A, Cramaro A, Pescini F, Lucente G, Wolfe CD, Inzitari D; European Registers of Stroke (EROS) Project.

Eur J Neurol. 2011 May;18(5):686-94. doi: 10.1111/j.1468-1331.2010.03207.x. Epub 2010 Sep 14.

PMID:
20840380
[PubMed - indexed for MEDLINE]
15.

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.

Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P; FREEDOMS Study Group.

N Engl J Med. 2010 Feb 4;362(5):387-401. doi: 10.1056/NEJMoa0909494. Epub 2010 Jan 20.

PMID:
20089952
[PubMed - indexed for MEDLINE]
Free Article
16.

Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry.

Kobayashi A, Czlonkowska A, Ahmed N, Romanowicz S, Glonek M, Nyka WM, Opala G, Wahlgren N; SITS Poland Collaborative Group.

Acta Neurol Scand. 2010 Oct;122(4):229-36. doi: 10.1111/j.1600-0404.2009.01294.x. Epub 2009 Nov 16.

PMID:
19919643
[PubMed - indexed for MEDLINE]
17.

Focusing radially polarized light by a concentrically corrugated silver film without a hole.

Wróbel P, Pniewski J, Antosiewicz TJ, Szoplik T.

Phys Rev Lett. 2009 May 8;102(18):183902. Epub 2009 May 8.

PMID:
19518872
[PubMed]
18.

Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.

Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici MG, Mattle HP, Rothwell PM; PERFORM Study Investigators.

Cerebrovasc Dis. 2009;27(5):509-18. doi: 10.1159/000212671. Epub 2009 Apr 16.

PMID:
19372653
[PubMed - indexed for MEDLINE]
19.

Incidence of stroke in Europe at the beginning of the 21st century.

European Registers of Stroke (EROS) Investigators, Heuschmann PU, Di Carlo A, Bejot Y, Rastenyte D, Ryglewicz D, Sarti C, Torrent M, Wolfe CD.

Stroke. 2009 May;40(5):1557-63. doi: 10.1161/STROKEAHA.108.535088. Epub 2009 Mar 26.

PMID:
19325154
[PubMed - indexed for MEDLINE]
Free Article
20.

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.

Segal BM, Constantinescu CS, Raychaudhuri A, Kim L, Fidelus-Gort R, Kasper LH; Ustekinumab MS Investigators.

Lancet Neurol. 2008 Sep;7(9):796-804. doi: 10.1016/S1474-4422(08)70173-X.

PMID:
18703004
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk